NCOG-05. IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS

BACKGROUND: The goal of treatment of primary central nervous system lymphoma patients is to improve survival, without compromising neurocognitive functioning. The aim of this study was to analyze the effect of Rituximab and low-dose whole brain radiotherapy (WBRT) on cognition. METHODS: 199 patients...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: van der Meulen, Matthijs, Dirven, Linda, Habets, Esther, Bakunina, Katerina, Taphoorn, Martin, van den Bent, Martin, Issa, Samar, Doorduijn, Jeanette K, Bromberg, Jacoline E C
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Neuro-Cognitive Outcomes
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847905/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.666
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы